In the current study, diosgenin-etodolac and diosgenin-naproxen conjugates have been synthesized using Steglich reaction. The synthesized compound 2 and 3 were purified using column chromatography and characterized with the help of modern spectroscopic techniques like 1H, 13C NMR, FT-IR, UV-Visible spectroscopy and mass spectrometry. The geometries of both the compounds were optimized in the ground state by density function theory at the B3LYP/6-31G(d,p) level. These synthesized compounds were evaluated in vitro for their anti-cancer activity against SiHa cells which demonstrated an increased apoptotic activity in comparison to the parent compound i.e. diosgenin. Molecular docking studies were carried out to investigate the inhibitory action of steroidal derivatives against the HPV16 E7 (PDBID- 2B9D) and HPV18 E2 (PDBID- 1F9F) proteins. The result of molecular docking revealed good interactions between compound 2 and 3 with the selected proteins. The computational analysis data and experimental data were in conformation with each other. Molecular simulation was performed for 50ns to access the conformational stability and fluctuation of protein ligand complexes during the simulation.
Read full abstract